Noble, John Matthew B.
HRN: 21-41-69 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
CEFUROXIME 750MG (VIAL)
06/01/2022
06/07/2022
IV
750mg Ld, Then 375mg
Q8h
Supracondylar Fracture
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes